...
首页> 外文期刊>Anaesthesia: Journal of the Association of Anaesthetists of Great Britain and Ireland >Arrhythmogenic risk of pulmonary artery catheterisation in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation
【24h】

Arrhythmogenic risk of pulmonary artery catheterisation in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation

机译:严重主动脉瓣狭窄患者行经导管主动脉瓣植入术的肺动脉导管性心律失常风险

获取原文
获取原文并翻译 | 示例
           

摘要

Many clinicians consider severe aortic stenosis to be a contraindication to pulmonary artery catheterisation, except during open heart surgery with cardiopulmonary bypass. This is due to the perceived high risk of arrhythmia, although the true incidence of ventricular tachycardia and fibrillation remains unclear. We conducted a retrospective study to estimate the incidence of severe arrhythmias during pulmonary artery catheterisation in 380 patients with severe aortic stenosis scheduled for transcatheter aortic valve implantation. Ventricular fibrillation was seen in only one patient (0.26%), and this was successfully terminated by external defibrillation. No episodes of ventricular tachycardia were recorded and there were also no arrhythmias during removal of the catheter. We have therefore concluded that pulmonary artery catheterisation in patients with severe aortic stenosis is not associated with a high incidence of ventricular fibrillation or tachycardia, allowing pulmonary artery pressure monitoring to be performed relatively safely in such patients.
机译:许多临床医生认为,严重的主动脉瓣狭窄是肺动脉导管插入术的禁忌症,但在进行有心肺旁路手术的心脏直视手术期间除外。这是由于心律失常的高风险所致,尽管尚不清楚室性心动过速和纤颤的真正发生率。我们进行了一项回顾性研究,以评估380例计划经导管主动脉瓣膜植入术的严重主动脉瓣狭窄患者在肺动脉插管期间发生严重心律不齐的发生率。仅一名患者(0.26%)出现室颤,并通过外部除颤成功终止。没有记录到室性心动过速发作,并且在移除导管期间也没有心律不齐。因此,我们得出结论,患有严重主动脉瓣狭窄的患者的肺动脉导管插入术与心室纤颤或心动过速的高发生率无关,因此可以在此类患者中相对安全地进行肺动脉压监测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号